Zusammenfassung
Der Pancoast-Tumor (Sulcus-superior-Tumor) ist eine Sonderform des Lungenkarzinoms
mit Infiltration der oberen Thoraxapertur, die durch Schulterschmerz und eventuell
Horner-Syndrom klinisch auffällig wird. Die häufig verspätete Diagnose und die komplexe
Anatomie der Region stellen eine Herausforderung für die Therapeuten dar. Dieser Beitrag
schildert, wie moderne Diagnostik und multimodale Behandlung die Prognose der Erkrankung
positiv beeinflussen können.
Abstract
Pancoast or superior pulmonary sulcus tumour is a subset of lung carcinoma that invades
the structures of the thoracic inlet – first ribs, distal roots of the brachial plexus,
stellate ganglion, vertebrae, and subclavian vessels. The first symptom is usually
shoulder pain; consequently, most patients are initially treated for osteoarthritis.
Late diagnosis is common. Success of therapy depends on an accurate staging: standard
imaging with CT scan of the chest, PET-CT scan, brain MRI are needed to rule out distant
metastases, endobronchial ultrasound-guided needle biopsy (EBUS-TBNA) or mediastinoscopy
are mandatory for reliable nodal staging. An MRI of the thoracic inlet allows to clearly
define the boundaries of local invasion. Modern management of Pancoast tumour includes
induction concurrent chemoradiotherapy followed by surgical resection. As compared
with historical series treated by preoperative radiation, a trimodally approach did
enhance complete resection rates and perhaps long-term survival – from about 30% 5-year
survival rate to 60% in R0-resected patients. In patients who have unresectable but
non-metastatic Pancoast tumours and appropriate performance status, definitive concurrent
chemoradiotherapy and radiotherapy are recommended options.
Schlüsselwörter
Lungenkarzinom - Chemotherapie - Radiotherapie - Chirurgie
Key words
lung cancer - chemotherapy - radiotherapy - surgery